Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

microRNA-206 modulates the hepatic expression of the organic anion transporting polypeptide 1B1.

El Saadany T, van Rosmalen B, Gai Z, Hiller C, Verheij J, Stieger B, van Gulik T, Visentin M, Kullak-Ublick GA.

Liver Int. 2019 Aug 13. doi: 10.1111/liv.14212. [Epub ahead of print]

PMID:
31408569
2.

Human MRP2 exports MC-LR but not the glutathione conjugate.

Kaur G, Fahrner R, Wittmann V, Stieger B, Dietrich DR.

Chem Biol Interact. 2019 Jul 23;311:108761. doi: 10.1016/j.cbi.2019.108761. [Epub ahead of print]

PMID:
31348918
3.

A rare cause of a cholestatic jaundice in a North African teenager.

Schreiner P, Stieger B, McLin V, Rougemont AL, Keitel V, Dröge C, Müllhaupt B.

Liver Int. 2019 Apr 25. doi: 10.1111/liv.14122. [Epub ahead of print] Review.

PMID:
31021034
4.

Organic anion‑transporting polypeptides contribute to the uptake of curcumin and its main metabolites by human breast cancer cells: Impact on antitumor activity.

Jaerapong N, Jamil QA, Riha J, Milovanovic D, Krupitza G, Stieger B, Jarukomjorn K, Jäger W.

Oncol Rep. 2019 Apr;41(4):2558-2566. doi: 10.3892/or.2019.7011. Epub 2019 Feb 14.

PMID:
30816509
5.

Effect of a Common Genetic Variant (p.V444A) in the Bile Salt Export Pump on the Inhibition of Bile Acid Transport by Cholestatic Medications.

Ali I, Khalid S, Stieger B, Brouwer KLR.

Mol Pharm. 2019 Mar 4;16(3):1406-1411. doi: 10.1021/acs.molpharmaceut.8b01124. Epub 2019 Jan 25.

PMID:
30608704
6.

Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients.

Rau M, Schmitt J, Berg T, Kremer AE, Stieger B, Spanaus K, Bengsch B, Romero MR, Marin JJ, Keitel V, Klinker H, Tony HP, Müllhaupt B, Geier A.

PLoS One. 2018 Dec 3;13(12):e0208225. doi: 10.1371/journal.pone.0208225. eCollection 2018.

7.

Age-dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers.

Sargiacomo C, El-Kehdy H, Pourcher G, Stieger B, Najimi M, Sokal E.

Hepatol Commun. 2018 Apr 6;2(6):693-702. doi: 10.1002/hep4.1174. eCollection 2018 Jun.

8.

Imaging techniques to study drug transporter function in vivo.

Tournier N, Stieger B, Langer O.

Pharmacol Ther. 2018 Sep;189:104-122. doi: 10.1016/j.pharmthera.2018.04.006. Epub 2018 Apr 22. Review.

PMID:
29684469
9.

Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.

Nicolaï J, Thevelin L, Bing Q, Stieger B, Chanteux H, Augustijns P, Annaert P.

Pharm Res. 2017 Nov;34(11):2336-2348. doi: 10.1007/s11095-017-2241-0. Epub 2017 Aug 21.

10.

β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine.

Mayati A, Moreau A, Denizot C, Stieger B, Parmentier Y, Fardel O.

Eur J Pharm Sci. 2017 Aug 30;106:302-312. doi: 10.1016/j.ejps.2017.06.010. Epub 2017 Jun 8.

PMID:
28603032
11.

Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.

Stieger B, Mahdi ZM.

J Pharm Sci. 2017 Sep;106(9):2295-2301. doi: 10.1016/j.xphs.2017.03.023. Epub 2017 Apr 3. Review.

PMID:
28385542
12.

Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.

Mayati A, Moreau A, Le Vée M, Stieger B, Denizot C, Parmentier Y, Fardel O.

Int J Mol Sci. 2017 Apr 4;18(4). pii: E764. doi: 10.3390/ijms18040764. Review.

13.

Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.

Chedik L, Bruyere A, Le Vee M, Stieger B, Denizot C, Parmentier Y, Potin S, Fardel O.

PLoS One. 2017 Jan 18;12(1):e0169480. doi: 10.1371/journal.pone.0169480. eCollection 2017.

14.

Inhibition of SLC drug transporter activities by environmental bisphenols.

Bruyere A, Hubert C, Le Vee M, Chedik L, Sayyed K, Stieger B, Denizot C, Parmentier Y, Fardel O.

Toxicol In Vitro. 2017 Apr;40:34-44. doi: 10.1016/j.tiv.2016.12.009. Epub 2016 Dec 15.

PMID:
27989701
15.

Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.

Visentin M, van Rosmalen BV, Hiller C, Bieze M, Hofstetter L, Verheij J, Kullak-Ublick GA, Koepsell H, Phoa SS, Tamai I, Bennink RJ, van Gulik TM, Stieger B.

Drug Metab Dispos. 2017 Feb;45(2):166-173. doi: 10.1124/dmd.116.072371. Epub 2016 Nov 30.

PMID:
27903597
16.

Recent advances in understanding hepatic drug transport.

Stieger B, Hagenbuch B.

F1000Res. 2016 Oct 6;5:2465. eCollection 2016. Review.

17.

Intestinal and Hepatocellular Transporters: Therapeutic Effects and Drug Interactions of Herbal Supplements.

Stieger B, Mahdi ZM, Jäger W.

Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:399-416. doi: 10.1146/annurev-pharmtox-010716-105010. Epub 2016 Sep 14. Review.

PMID:
27648763
18.

Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.

Rau M, Stieger B, Monte MJ, Schmitt J, Jahn D, Frey-Wagner I, Raselli T, Marin JJ, Müllhaupt B, Rogler G, Geier A.

Inflamm Bowel Dis. 2016 Oct;22(10):2382-9. doi: 10.1097/MIB.0000000000000879.

19.

Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate.

Sayyed K, Vee ML, Abdel-Razzak Z, Jouan E, Stieger B, Denizot C, Parmentier Y, Fardel O.

Toxicology. 2016 Jul 1;363-364:58-71. doi: 10.1016/j.tox.2016.07.011. Epub 2016 Jul 19.

20.

Proteomic Analysis of the Rat Canalicular Membrane Reveals Expression of a Complex System of P4-ATPases in Liver.

Chaubey PM, Hofstetter L, Roschitzki B, Stieger B.

PLoS One. 2016 Jun 27;11(6):e0158033. doi: 10.1371/journal.pone.0158033. eCollection 2016.

Supplemental Content

Loading ...
Support Center